News & Impact

You are here

Clinical Integration Report on Using the Armeo®Spring in a Parallel Setting for Neurological Injury Rehabilitation

PUBLICATION: 
Case Report
Authors: 
Tomoko Kitago
Year Published: 
2019
Publisher: 
Hocoma. 2019 Oct 18
Full-Text on Hocoma

Abstract

Burke Neurological Institute has been working with the ArmeoSpring by Hocoma since January 2017 in which we had utilized the devices for a clinical research trial to look at effects of staff to participant ratio (1:1 vs. 1:2) and treatment dosage (30 min. vs. 60 min) in an outpatient research setting. Here we would like to share our experience with using the devices in the 1:2 staffing ratio.

NOTE: This clinical experience report is meant to serve as an example of how the ArmeoSpring is integrated into one particular rehabilitation centre. It is not necessarily a standard recommendation from Hocoma.

Conditions & Recovery

Stroke icon
Stroke is the leading cause of disability in the U.S.
Traumatic Brain Injury icon
In the U.S., over 5.3 million adults and children live with TBI.
Spinal Cord Injury icon
Around the world, between 300,000 and 500,000 people are living with a SCI.
Motor Recovery Icon
Write and walk again.